世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米スワブ採取キット市場予測 2023-2032

北米スワブ採取キット市場予測 2023-2032


NORTH AMERICA SWABS COLLECTION KIT MARKET FORECAST 2023-2032

主な調査結果 北米のスワブ採取キット市場は、予測期間2023-2032年にCAGR 2.49%を記録すると予測される。カナダ保健省（Health Canada）や米国食品医薬品局（FDA）などの規制機関は、綿棒採取キットの安全性、性... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Inkwood Research
インクウッドリサーチ 		2023年7月23日 US$1,600
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		2-3営業日以内 166 英語

　

サマリー

主な調査結果
北米のスワブ採取キット市場は、予測期間2023-2032年にCAGR 2.49%を記録すると予測される。カナダ保健省（Health Canada）や米国食品医薬品局（FDA）などの規制機関は、綿棒採取キットの安全性、性能、品質基準を定めている。
市場インサイト
北米のスワブ採取キット市場成長評価では、カナダと米国が評価対象となる。カナダでは当初、迅速ポイントオブケア検査は承認されなかった。しかしその後、カナダ保健省はCOVID-19患者の急増に対応してこれらの検査を承認した。2020年10月、連邦政府はCOVID-19迅速検査2,050万件の取得契約を締結した。さらに、世界保健機関（WHO）の報告によると、2023年7月まで、カナダでは合計460万件のCOVID-19感染者が発生している。その結果、COVID-19感染の検出と診断、ウイルスの蔓延の監視、不可欠な公衆衛生イニシアチブの実施に重要な役割を果たすため、綿棒採取キットの需要が大幅に増加している。
さらに、SARS-CoV-2ウイルスの亜種が出現し、その一部はより感染性が高く、重症化する可能性があるため、監視とモニタリングの強化が必要となった。綿棒採取キットによって容易になったゲノム配列決定は、これらの変異を検出し追跡する上で極めて重要である。さらに、診断検査の研究開発の重要性を認識し、カナダ政府は革新的な検査技術、特に綿棒採取技術や材料の進歩に投資を行ってきた。こうした要因がカナダ市場の成長を促進している。
競合他社の洞察
市場参入企業には、Thermo Fisher Scientific Inc、Becton、Formlabs、Puritan Medical Productsなどがある。
弊社のレポート提供内容は以下の通りです：
- 市場全体の主要調査結果を探る
- 市場ダイナミクスの戦略的内訳（促進要因、阻害要因、機会、課題）
- 全セグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測
- 市場セグメンテーション：主要セグメントの徹底的な評価と市場予測
- 地域別分析：言及された地域と国レベルのセグメントを市場シェアとともに評価
- 主要分析：ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要購買基準など。
- 競争環境は、要因や市場シェアなどに基づく主要企業の理論的説明である。
- 企業プロファイリング：詳細な会社概要、提供する製品・サービス、SCOT分析、最近の戦略的展開など


ページTOPに戻る


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON SWABS COLLECTION KIT MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. PREVENTIVE CARE ENABLES EARLY DETECTION AND CONTAINMENT OF INFECTIOUS DISEASES
2.5.2. NASOPHARYNGEAL SWABS ARE MORE EFFICIENT FOR INFECTIOUS DISEASES
2.5.3. POINT-OF-CARE TESTING ENABLES RAPID & TIMELY DIAGNOSIS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING NEED FOR QUICK & ACCURATE DIAGNOSIS OF INFECTIOUS DISEASES
3.1.2. SURGING DEMAND FOR DIAGNOSTIC TESTING
3.1.3. INCREASING HEALTHCARE INVESTMENTS
3.2. KEY RESTRAINTS
3.2.1. AVAILABILITY OF ALTERNATIVES
3.2.2. STRICT GOVERNMENT REGULATIONS
3.2.3. INCONCLUSIVE RESULTS DUE TO OPERATOR ERROR
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TIP MATERIAL TYPE
5.1. POLYESTER
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. COTTON
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. RAYON
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. FOAM
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. OTHER TIP MATERIAL TYPES
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
6. MARKET BY SAMPLE TYPE
6.1. NASOPHARYNGEAL SWABS
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. OROPHARYNGEAL SWABS
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
6.3. OTHER SAMPLE TYPES
6.3.1. MARKET FORECAST FIGURE
6.3.2. SEGMENT ANALYSIS
7. MARKET BY END-USER
7.1. DIAGNOSTIC CENTERS
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. HOSPITALS & CLINICS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. HOME HEALTHCARE
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
7.4. OTHER END-USERS
7.4.1. MARKET FORECAST FIGURE
7.4.2. SEGMENT ANALYSIS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA SWABS COLLECTION KIT MARKET DRIVERS
8.1.3. NORTH AMERICA SWABS COLLECTION KIT MARKET CHALLENGES
8.1.4. NORTH AMERICA SWABS COLLECTION KIT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS OPERATING IN NORTH AMERICA SWABS COLLECTION KIT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES SWABS COLLECTION KIT MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA SWABS COLLECTION KIT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. BECTON, DICKINSON AND COMPANY
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. BTNX INC
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. FORMLABS
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. HARDY DIAGNOSTICS
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. HIMEDIA LABORATORIES
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. LABORATORY CORPORATION OF AMERICA HOLDINGS
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. LUCENE DIAGNOSTICS
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. PURITAN MEDICAL PRODUCTS
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. THERMO FISHER SCIENTIFIC INC
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. VIRCELL SL
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES

　

ページTOPに戻る


　

Summary

KEY FINDINGS
The North America swabs collection kit market is anticipated to register a CAGR of 2.49% during the forecast period, 2023-2032. Regulatory bodies like Health Canada and the United States Food and Drug Administration (FDA) put forth the safety, performance, and quality standards for swabs collection kits.
MARKET INSIGHTS
Canada and the United States are evaluated for the North America swabs collection kit market growth assessment. Initially, rapid point-of-care tests did not receive approval in Canada. However, later on, Health Canada approved these tests in response to the surge in COVID-19 cases. In October 2020, the federal government entered into an agreement for the acquisition of 20.5 million rapid COVID-19 tests. Further, as reported by the World Health Organization (WHO), until July 2023, Canada has witnessed a total of 4.6 million COVID-19 cases. Consequently, the swab collection kits demands have risen significantly due to their vital role in detecting and diagnosing COVID-19 infections, monitoring the virus's spread, and implementing essential public health initiatives.
Accordingly, the emergence of additional SARS-CoV-2 virus variants, some of which may be more transmissible or severe, necessitated heightened surveillance and monitoring efforts. Genomic sequencing, facilitated by swab collection kits, is crucial in detecting and tracking these variations. Moreover, in recognition of the importance of diagnostic testing research and development, the Canadian government has made investments in innovative testing technologies, notably advancements in swab-collecting techniques and materials. Such factors facilitate market growth in Canada.
COMPETITIVE INSIGHTS
Some of the prominent players in the market include Thermo Fisher Scientific Inc, Becton, Formlabs, Puritan Medical Products, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON SWABS COLLECTION KIT MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. PREVENTIVE CARE ENABLES EARLY DETECTION AND CONTAINMENT OF INFECTIOUS DISEASES
2.5.2. NASOPHARYNGEAL SWABS ARE MORE EFFICIENT FOR INFECTIOUS DISEASES
2.5.3. POINT-OF-CARE TESTING ENABLES RAPID & TIMELY DIAGNOSIS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING NEED FOR QUICK & ACCURATE DIAGNOSIS OF INFECTIOUS DISEASES
3.1.2. SURGING DEMAND FOR DIAGNOSTIC TESTING
3.1.3. INCREASING HEALTHCARE INVESTMENTS
3.2. KEY RESTRAINTS
3.2.1. AVAILABILITY OF ALTERNATIVES
3.2.2. STRICT GOVERNMENT REGULATIONS
3.2.3. INCONCLUSIVE RESULTS DUE TO OPERATOR ERROR
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TIP MATERIAL TYPE
5.1. POLYESTER
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. COTTON
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. RAYON
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. FOAM
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. OTHER TIP MATERIAL TYPES
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
6. MARKET BY SAMPLE TYPE
6.1. NASOPHARYNGEAL SWABS
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. OROPHARYNGEAL SWABS
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
6.3. OTHER SAMPLE TYPES
6.3.1. MARKET FORECAST FIGURE
6.3.2. SEGMENT ANALYSIS
7. MARKET BY END-USER
7.1. DIAGNOSTIC CENTERS
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. HOSPITALS & CLINICS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. HOME HEALTHCARE
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
7.4. OTHER END-USERS
7.4.1. MARKET FORECAST FIGURE
7.4.2. SEGMENT ANALYSIS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA SWABS COLLECTION KIT MARKET DRIVERS
8.1.3. NORTH AMERICA SWABS COLLECTION KIT MARKET CHALLENGES
8.1.4. NORTH AMERICA SWABS COLLECTION KIT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS OPERATING IN NORTH AMERICA SWABS COLLECTION KIT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES SWABS COLLECTION KIT MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA SWABS COLLECTION KIT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. BECTON, DICKINSON AND COMPANY
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. BTNX INC
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. FORMLABS
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. HARDY DIAGNOSTICS
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. HIMEDIA LABORATORIES
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. LABORATORY CORPORATION OF AMERICA HOLDINGS
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. LUCENE DIAGNOSTICS
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. PURITAN MEDICAL PRODUCTS
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. THERMO FISHER SCIENTIFIC INC
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. VIRCELL SL
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Inkwood Research社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630